Haemonetics (HAE) Change in Receivables (2009 - 2026)

Haemonetics has reported Change in Receivables for 18 years, with the latest figure at -$297000.0 in Q2 2026.

• On a quarterly basis, Change in Receivables rose 91.65% year-over-year to -$297000.0 in Q2 2026; TTM through Jun 2026 was $18.1 million, a 813.37% increase from a year earlier, with the FY2026 full-year figure at $14.9 million, up 313.93% from the prior year.
• Change in Receivables was -$297000.0 for Q2 2026 at Haemonetics, down from $22.2 million in the prior quarter.
• The five-year high for Change in Receivables was $30.6 million in Q4 2023, with the low at -$11.1 million in Q4 2025.
• Average Change in Receivables over 5 years is $4.0 million, with a median of $51000.0 recorded in 2023.
• The largest YoY upside for Change in Receivables was 618.57% in 2024 against a maximum downside of 7060.78% in 2024.
• Over 5 years, Change in Receivables stood at $7.3 million in 2022, then soared by 317.63% to $30.6 million in 2023, then slumped by 94.21% to $1.8 million in 2024, then sank by 724.39% to -$11.1 million in 2025, then jumped by 97.31% to -$297000.0 in 2026.
• The last three Change in Receivables figures came in at -$297000.0 (Q2 2026), $22.2 million (Q1 2026), and -$11.1 million (Q4 2025), per Business Quant data.